CDK2 and hepatocellular carcinoma: In our previously research, U12, a UDCA derivative, was found to show anti-hepatoma activities via mTOR/S6K1, cyclinD1/CDK2/4 and caspase-dependent apoptotic signaling pathways in hepatocellular carcinoma cells.